
Audentes Therapeutics
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases..
Market cap
$23.1m
Enterprise value
($67m)
Share price
$1.01 BOLD
Authorizing premium user...
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases..